These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22695942)

  • 1. Immunological orchestration of liver fibrosis.
    Tanaka H; Leung PS; Kenny TP; Gershwin ME; Bowlus CL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):220-9. PubMed ID: 22695942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.
    Leung PS; Wang J; Naiyanetr P; Kenny TP; Lam KS; Kurth MJ; Gershwin ME
    J Autoimmun; 2013 Mar; 41():79-86. PubMed ID: 23352659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concept on the pathogenesis and treatment of primary biliary cirrhosis.
    Reshetnyak VI
    World J Gastroenterol; 2006 Dec; 12(45):7250-62. PubMed ID: 17143938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Wu SJ; Yang YH; Tsuneyama K; Leung PS; Illarionov P; Gershwin ME; Chuang YH
    Hepatology; 2011 Mar; 53(3):915-25. PubMed ID: 21374662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.
    Gershwin ME; Ansari AA; Mackay IR; Nakanuma Y; Nishio A; Rowley MJ; Coppel RL
    Immunol Rev; 2000 Apr; 174():210-25. PubMed ID: 10807518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
    Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
    Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis.
    Yeaman SJ; Kirby JA; Jones DE
    Immunol Rev; 2000 Apr; 174():238-49. PubMed ID: 10807520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
    Tsuneyama K; Baba H; Morimoto Y; Tsunematsu T; Ogawa H
    J Med Invest; 2017; 64(1.2):7-13. PubMed ID: 28373632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis.
    Nishio A; Coppel R; Ishibashi H; Gershwin ME
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in the pathogenesis of primary biliary cirrhosis.
    Charatcharoenwitthaya P; Lindor KD
    Ann Hepatol; 2005; 4(3):161-75. PubMed ID: 16177655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunology of primary biliary cirrhosis: the end of the beginning?
    Palmer JM; Kirby JA; Jones DE
    Clin Exp Immunol; 2002 Aug; 129(2):191-7. PubMed ID: 12165073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.
    Kaplan MM
    Am J Gastroenterol; 2004 Nov; 99(11):2147-9. PubMed ID: 15554995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models.
    Ueno Y; Moritoki Y; Shimosegawa T; Gershwin ME
    J Gastroenterol; 2007 Mar; 42(3):189-95. PubMed ID: 17380276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
    Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
    J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enigma of primary biliary cirrhosis.
    Selmi C; Ichiki Y; Invernizzi P; Podda M; Gershwin ME
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):73-81. PubMed ID: 15879614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopathology of primary biliary cirrhosis: thoughts for the millennium.
    Sasaki M; Ansari AA; Nakanuma Y; Coppel RL; Keeffe EB; Gershwin ME
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):1-10. PubMed ID: 10722225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies.
    Nakanuma Y; Harada K; Kaji K; Terasaki S; Tsuneyama K; Moteki S; Van de Water J; Leung PS; Gershwin ME
    Liver; 1997 Dec; 17(6):281-7. PubMed ID: 9455733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X and why of xenobiotics in primary biliary cirrhosis.
    Rieger R; Gershwin ME
    J Autoimmun; 2007; 28(2-3):76-84. PubMed ID: 17360156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of primary biliary cirrhosis.
    Concepcion AR; Medina JF
    Curr Pharm Des; 2015; 21(18):2401-13. PubMed ID: 25777756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.